Latest Advances

  • Journal: Molecules (Basel, Switzerland)
  • Published —
CD47 in the Brain and Neurodegeneration: An Update on the Role in Neuroinflammatory Pathways.
  • Condition: Myositis/Myasthenia after Pembrolizumab in Patient with Bladder Cancer with an Autoimmunity-Associated HLA
  • Journal: International journal of molecular sciences
  • Treatment Used: Pembrolizumab Discontinuation, Pyridostigmine, and Steroids-Based Therapy
  • Number of Patients: 1
  • Published —
This case report describes a patient with a metastatic bladder cancer who developed myositis signs (M) and a myasthenia-like syndrome (MLS) during treatment with pembrolizumab treated with pembrolizumab discontinuation, pyridostigmine, and steroids-based therapy.
  • Journal: Cell death & disease
  • Published —
ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A.
  • Journal: Medicina (Kaunas, Lithuania)
  • Published —
Racial Differences in Incident Genitourinary Cancer Cases Captured in the National Cancer Database.
  • Condition: Muscle-Invasive Bladder Cancer (MIBC)
  • Journal: Frontiers in immunology
  • Treatment Used: Chemotherapy Combined with Immunotherapy
  • Number of Patients: 1
  • Published —
This case report describes a 50-year-old male diagnosed with muscle-invasive bladder cancer (MIBC) treated with chemotherapy combined with immunotherapy.
  • Condition: Intra-Abdominal Hypertension-Induced Gastroesophageal Intussusception (GEI)
  • Journal: The American journal of case reports
  • Treatment Used: Ascites Drainage
  • Number of Patients: 1
  • Published —
This case report describes an 81-year-old man who developed an intra-abdominal hypertension-induced gastroesophageal intussusception (GEI) after transurethral resection of a bladder tumor treated with ascites drainage.
  • Condition: Non-Muscle Invasive Bladder Cancer (NIMBC)
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Intravesical Gemcitabine
  • Number of Patients: 1222
  • Published —
This review of the literature assessed the effectiveness of intravesical gemcitabine instillation for the treatment of patients with non-muscle invasive bladder cancer (NMIBC).
  • Journal: Journal of cancer research and therapeutics
  • Published —
Prognostic and clinicopathologic value of ki-67 and profilin 1 immunohistochemical expression in primary pT1 urothelial bladder cancer.
  • Journal: Journal of cancer research and therapeutics
  • Published —
Bacillus Calmette-Guérin-induced perinuclear antineutrophil cytoplasmic antibodies associated vasculitis in bladder cancer.
  • Condition: Locally Advanced Prostate Cancer (LAPC) with Bladder Infiltration
  • Journal: Hinyokika kiyo. Acta urologica Japonica
  • Treatment Used: Robot-Assisted Radical Cystoprostatectomy (RARC)
  • Number of Patients: 1
  • Published —
This case report describes a 71-year-old man diagnosed with locally advanced prostate cancer (LAPC) with bladder infiltration treated with robot-assisted radical cystoprostatectomy (RARC).
  • Journal: Nature communications
  • Published —
Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex.
  • Journal: Actas urologicas espanolas
  • Published —
The use of ileocecal pouch with appendix as an urethral substitute in patients who are willing to have a orthotopic bladder replacement - point of technique.
Showing 1-12 of 392